GLP-1 Travel Master Guide: TSA, Cruise, International, and Storage Reference

GLP-1 Travel Master Guide: TSA, Cruise, International, and Storage Reference

Updated on: 2026-05-07

GLP-1 Travel Master Guide: TSA, Cruise, International, and Storage Reference

🧮 Plan dose dates around your trip

Traveling for a week or longer? The free GLP1 Calculator's Titration Schedule maps weekly dose dates against the trip — useful for tracking pre-travel injections, in-flight days, and arrival timing without missing a week.

Open Calculator →

📈 Track your weekly doses across the trip

The free GLP-1 Plotter logs each dose date and builds a plasma-level curve — useful for visualizing where each injection falls during your trip and confirming you don't miss a week.

Open Plotter →

Traveling with GLP-1 medications, peptides, or injectable prescriptions involves a network of overlapping rules: TSA security, airline policies, cruise line medical protocols, international customs documentation, and the cold-chain storage profile each medication carries. This master guide is an informational reference that consolidates documented rules across all major travel contexts — with links to the individual destination, airline, and storage references for the specific scenarios. Informational only — not medical or legal advice.


Table of Contents

  1. Air Travel & TSA
  2. Brand-Name GLP-1 Medications
  3. Cruise Lines
  4. International Customs & Borders
  5. Storage, BAC Water & Reconstitution
  6. Travel Gear Reference
  7. FAQ
  8. Disclaimer

1) Air Travel & TSA

The TSA's medical screening guidance documents prescription injectables — including GLP-1 pens, peptide vials, and BAC water — under the medical-liquids exemption. Quantities greater than 3.4 oz (100 mL) are documented as permitted in carry-on when declared at security, and pen needles or sterile syringes accompanying the injectable are documented as permitted alongside.

For the full documented TSA reference covering peptides, GLP-1s, CJC, TRT, and BAC water carriage:


2) Brand-Name GLP-1 Medications

Each major GLP-1 brand documents its own storage profile and travel considerations. The four most commonly referenced for U.S. air travel:

The shared documented profile across all four: refrigeration at 36–46°F (2–8°C) before use, room-temperature ceiling of 86°F (30°C), no freezing, original carton for light protection.


3) Cruise Lines

Each major cruise line publishes its own documented policy for injectable medications, sharps disposal, and refrigeration. Standard documented practices across the industry: medications carried in carry-on with original packaging, sharps containers provided by Guest Services or stateroom attendant on request, and Medical Center cold storage available when pharmaceutical-grade refrigeration is required.

Per-cruise-line documented references:


4) International Customs & Borders

International itineraries layer destination-country medication import rules on top of TSA carry-on rules. Documented patterns vary substantially by region — most EU and UK airports document medical exemptions broadly comparable to TSA, while Middle East, Asia-Pacific, and select Latin American destinations document more specific declaration requirements.

Per-region documented references:


5) Storage, BAC Water & Reconstitution

The cold-chain profile during travel is the documented constraint for peptides and GLP-1 medications. Each compound has its own labeled temperature window; the universal references are 2–8°C refrigeration, an upper room-temperature ceiling, and avoidance of freezing.

Documented storage references:


6) Travel Gear Reference

Vialcase produces vial cases sized for the formats commonly referenced in GLP-1 and peptide travel: 3 mL peptide vials, 10 mL TRT-format vials, 30 mL BAC water bottles, and the syringes, alcohol pads, and pen needles in a typical reconstitution kit.

Browse all vial storage cases →


7) FAQ

What is the universally documented carry-on rule for GLP-1 medications?

TSA documents prescription injectables including all major GLP-1 medications (Ozempic®, Wegovy®, Mounjaro®, Zepbound®, and compounded semaglutide or tirzepatide) as permitted in carry-on under the medical-liquids exemption. Declaration at security screening is documented as part of the standard procedure.

What temperature range is documented as universal across GLP-1 medications?

The shared documented temperature profile across major GLP-1 medications is 36–46°F (2–8°C) refrigeration before use, with a room-temperature ceiling of 86°F (30°C) for varying durations after first use (Ozempic® 56 days; Wegovy® 28 days; Mounjaro® and Zepbound® 21 days). Freezing is not documented in any major GLP-1 manufacturer's labeling.

Do cruise lines document GLP-1 medications differently than airlines?

Cruise line documentation focuses on onboard storage (stateroom refrigerator vs. Medical Center cold storage), sharps disposal, and pre-cruise accommodations forms. Airline documentation focuses on TSA security and carry-on placement. The medication itself is documented under the same general medical-exemption framework across both contexts.

What is documented for international travel with GLP-1 medications?

EU and UK airports generally document medical exemptions consistent with TSA when prescription documentation accompanies the medication. Mexico, Caribbean, and Latin America destinations document personal-use carriage as permitted with original packaging and prescription documentation. Several Middle East and Asia-Pacific countries document specific pre-arrival declaration procedures; embassy or consulate verification ahead of travel is the documented standard.

Where is BAC water documented in the GLP-1 travel reference?

BAC water (bacteriostatic water) is documented as the standard diluent for reconstituting lyophilized peptides — including compounded semaglutide and tirzepatide. TSA documents it under the medical-liquids exemption alongside the medication it accompanies. Hospira's labeling documents a 28-day in-use period after first puncture under refrigeration; storage cases sized for BAC bottles alongside peptide vials are referenced in cruise and air travel literature.



Trademark notice: Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Vialcase is independent and is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any cruise line, airline, or pharmaceutical manufacturer referenced in this article. All brand and product names referenced are descriptive of publicly known products and remain the property of their respective owners.

⚠️ Disclaimer

This article is informational reference only on documented TSA, airline, cruise line, customs, and manufacturer storage policies for GLP-1 medications and peptides. It is not medical or legal advice and does not direct any specific clinical action. Verify current rules with TSA, the relevant airline, the cruise line's medical department, the destination country's customs authority, and the medication manufacturer for the specific itinerary. Refer to a licensed healthcare provider for clinical guidance specific to the medication.

Back to blog